Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 80
Selected: 0
NCT IDTitle
NCT00238615Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC
NCT00194740Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer
NCT00168896A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage
NCT00206505Neoadjuvant Taxotere
NCT01640782Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach
NCT00193050Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer
NCT00170378The Use of Low Molecular Weight Heparin in Traumatic Brain Injury
NCT00215930The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer
NCT01652820Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer
NCT00068341Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast Cancer
NCT00095654The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial
NCT001896575FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer
NCT00527761Taxotere/Temodar/Cisplatin Study in Melanoma Patients
NCT00193115Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast Cancer
NCT00214058Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer
NCT00005800Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer
NCT00288444Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
NCT00118131Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
NCT00118053Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer
NCT00194558Outcomes and Cost Consequences of Using an Internet Co-Management Module to Improve the Quality of Type 1 Diabetes Care
NCT00220064A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI Tumours
NCT01035528Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD)
NCT00193232Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancer
NCT00193128Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer
NCT00113347Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT00090610Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer
NCT00148070Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer
NCT00426127Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer
NCT00087035Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer
NCT00193284Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer
NCT00118508The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)
NCT00066885Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer
NCT00232479Dose Dense Carboplatin, Taxotere and Herceptin As Primary Systemic Therapy in Breast Cancer
NCT00390429Docetaxel and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
NCT00211224Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)
NCT00176059Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients
NCT00822471Feasibility and Impact of "ABCs of Diabetes" Self-Management Education Program at an Urban Public Library
NCT00270894Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients
NCT00318890Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck
NCT00268593Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer
NCT00257348Capecitabine and Docetaxel in Advanced/Recurrent Cervical Cancer
NCT00048087Iressa/Docetaxel in Non-Small-Cell Lung Cancer
NCT00196651HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection
NCT00190411Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type
NCT00210184Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer
NCT00002662Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer
NCT00193323Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients
NCT00193427Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer
NCT00043576ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere
NCT00193271Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer